Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 140

Similar articles for PubMed (Select 15975023)

1.

Predicting the potential public health impact of disease-modifying HIV vaccines in South Africa: the problem of subtypes.

Blower SM, Bodine EN, Grovit-Ferbas K.

Curr Drug Targets Infect Disord. 2005 Jun;5(2):179-92. Review.

PMID:
15975023
2.
3.

Forecasting the future of HIV epidemics: the impact of antiretroviral therapies & imperfect vaccines.

Blower S, Schwartz EJ, Mills J.

AIDS Rev. 2003 Apr-Jun;5(2):113-25. Review.

PMID:
12876900
4.
5.

Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa.

Amirfar S, Hollenberg JP, Abdool Karim SS.

J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):219-25.

PMID:
16951648
6.

The development of HIV-1 subtype C vaccines for Southern Africa.

Williamson AL.

IUBMB Life. 2002 Apr-May;53(4-5):207-8. Review.

PMID:
12120996
7.

Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.

Lian Y, Srivastava I, Gómez-Román VR, Zur Megede J, Sun Y, Kan E, Hilt S, Engelbrecht S, Himathongkham S, Luciw PA, Otten G, Ulmer JB, Donnelly JJ, Rabussay D, Montefiori D, van Rensburg EJ, Barnett SW.

J Virol. 2005 Nov;79(21):13338-49.

8.

HIV genetic diversity: biological and public health consequences.

Butler IF, Pandrea I, Marx PA, Apetrei C.

Curr HIV Res. 2007 Jan;5(1):23-45. Review.

PMID:
17266555
9.

The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.

Andersson KM, Stover J.

Vaccine. 2011 Aug 18;29(36):6092-9. doi: 10.1016/j.vaccine.2011.06.060. Epub 2011 Jun 22.

PMID:
21703322
10.
11.

Potential impact of low efficacy HIV-1 vaccines in populations with high rates of infection.

Anderson RM, Swinton J, Garnett GP.

Proc Biol Sci. 1995 Aug 22;261(1361):147-51.

PMID:
7568269
12.

Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.

Patel MM, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059. Review.

13.
14.

A catastrophe in the 21st century: the public health situation in South Africa following HIV/AIDS.

Walker AR, Walker BF, Wadee AA.

J R Soc Promot Health. 2005 Jul;125(4):168-71.

PMID:
16094927
15.

Potential public health impact of imperfect HIV type 1 vaccines.

Anderson R, Hanson M.

J Infect Dis. 2005 Feb 1;191 Suppl 1:S85-96. Review.

16.

Molecular variants of HIV-1 and their impact on vaccine development.

Quinn TC.

Int J STD AIDS. 1998;9 Suppl 1:2.

PMID:
9874106
17.

Human resources for treating HIV/AIDS: needs, capacities, and gaps.

Bärnighausen T, Bloom DE, Humair S.

AIDS Patient Care STDS. 2007 Nov;21(11):799-812.

PMID:
17944556
18.

The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model.

Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F, Newell ML, Lurie MN, Baltussen R, de Vlas SJ.

Vaccine. 2011 Aug 18;29(36):6100-6. doi: 10.1016/j.vaccine.2011.06.059. Epub 2011 Jun 22.

19.

Analytic insights into the population level impact of imperfect prophylactic HIV vaccines.

Abu-Raddad LJ, Boily MC, Self S, Longini IM Jr.

J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):454-67.

PMID:
17554215
20.

Modeling the potential public health impact of imperfect HIV vaccines.

Blower S.

J Infect Dis. 2005 Oct 15;192(8):1494-5; author reply 1495-6. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk